Abstract
Proteomic biomarker discovery, confirmation, and validation studies depend absolutely on great care in the management and documentation of preanalytical sources of variation. This consideration is particularly important for such complex and dynamic specimens as plasma. Clues to the awareness of the investigator are clarity about whether the specimen is serum or plasma, reasons stated for the choice, specification of the anticoagulant in the case of plasma, and statement about whether enrichment, depletion, or protease inhibition methods were deployed. This chapter provides a systematic discussion of preanalytical variables affecting plasma and serum and offers practical guidance for reducing undesirable variation in results from these sources.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Angal, S., and Dean, P.D. (1977). The effect of matrix on the binding of albumin to immobilized Cibacron Blue. Biochem J 167, 301–303.
Barker, P.E., Wagner, P.D., Stein, S.E., Bunk, D.M., Srivastava, S., and Omenn, G.S. (2006). Standards for plasma and serum proteomics in early cancer detection: A needs assessment report from the National Institute of Standards and Technology--National Cancer Institute Standards, Methods, Assays, Reagents and Technologies Workshop, August 18–19, 2005. Clin Chem 52, 1669–1674.
Bhatnagar, B.S., Bogner, R.H., and Pikal, M.J. (2007). Protein stability during freezing: separation of stresses and mechanisms of protein stabilization. Pharm Dev Technol 12, 505–523.
Bhaumik, G., Srivastava, K.K., Selvamurthy, W., and Purkayastha, S.S. (1995). The role of free radicals in cold injuries. Int J Biometeorol 38, 171–175.
Björhall, K., Miliotis, T., and Davidsson, P. (2005). Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics 5, 307–317.
Blomback, B., Hessel, B., Iwanaga, S., Reuterby, J., and Blomback, M. (1972). Primary structure of human fibrinogen and fibrin. J Biol Chem 247, 1496–1512.
Bowen, R.A., Hortin, G.L., Csako, G., Otañez, O.H., and Remaley, A.T. (2010). Impact of blood collection devices on clinical chemistry assays. Clin Biochem 43, 4–25.
Clarke, D.M., Baust, J.M., Van Buskirk, R.G., and Baust, J.G. (2004). Addition of anticancer agents enhances freezing-induced prostate cancer cell death: implications of mitochondrial involvement. Cryobiology 49, 45–61.
Conboy, J.J., Wood, K.G., Lame, M.E., Durham, R.A., and Geoghegan, K.F. (2008). Modification of amyloid-[beta](1-40) by a protease inhibitor creates risk of error in mass spectrometric quantitation of amyloid-[beta](1-42). Anal Biochem 382, 147–149.
Craft, D., Yi, J., and Gelfand, C. (2009). Time-dependent and sample-to-sample variations in human plasma peptidome are both minimized through use of protease inhibitors. Anal Lett 42, 1398–1406.
Deacon, C.F., and Holst, J.J. (2009). Immunoassays for the incretin hormones GIP and GLP-1. Best Pract Res Clin Endocrinol Metab 23, 425–432.
De Vriese, C., Gregoire, F., Lema-Kisoka, R., Waelbroeck, M., Robberecht, P., and Delporte, C. (2004). Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. Endocrinology 145, 4997–5005.
Doumas, B.T., Hause, L.L., Simuncak, D.M., and Breitenfeld, D. (1989). Differences between values for plasma and serum in tests performed in the Ektachem 700 XR Analyzer, and evaluation of “plasma separator tubes (PST).” Clin Chem 35, 151–153.
Findeisen, P., Peccerella, T., Post, S., Wenz, F., and Neumaier, M. (2008). Spiking of serum specimens with exogenous reporter peptides for mass spectrometry based protease profiling as diagnostic tool. Rapid Commun Mass Spectrom 22, 1223–1229.
Flower, L., Ahuja, R.H., Humphries, S.E., and Mohamed-Ali, V. (2000). Effects of sampler handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. Cytokine 12, 1712–1716.
Grubb, R.L., Black, A., Izmirlian, G., Hickey, T.P., Pinsky, P.F., Mabie, J.E., et al. (2009). Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomark Prevent 18, 748–751.
Gundry, R.L., White, M.Y., Nogee, J., Tchernyshyov, I., and Van Eyk, J.E. (2009). Assessment of albumin removal from an immunoaffinity spin column: critical implications for proteomic examination of the albuminome and albumin-depleted samples. Proteomics 9, 2021–2028.
Hamacher, M., Stephan, C., Eisenacher, M., Hardt, T., Marcus, K., and Meyer, H.E. (2008). Maintaining standardization: an update of the HUPO Brain Proteome Project. Expert Rev Proteomics 5, 165–173.
Hosnijeh, F.S., Krop, E.J.M., Portengen, Lt, Rabkin, C.S., Linseisen, J., Vineis, P., et al. (2010). Stability and reproducibility of simultaneously detected plasma and serum cytokine levels in asymptomatic subjects. Biomarkers 15, 140–148.
Hu, S., Loo, J.A., and Wong, D.T. (2007). Human saliva proteome analysis. Ann N Y Acad Sci 1098, 323–329.
Jacobsen, D.W., Gatautis, V.J., Green, R., Robinson, K., Savon, S.R., Secic, M., et al. (1994). Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem 40, 873–881.
Lippi, G., Franchini, M., Montagnana, M., Salvagno, G.L., Poli, G., and Guidi, G.C. (2006). Quality and reliability of routine coagulation testing: can we trust that sample? Blood Coagul Fibrinol 17, 513–519.
Long, T. (1993). Statistical power in the detection of matrix effects. Arch Pathol Lab Med 117, 387–392.
Lovestone, S., Francis, P., Kloszewska, I., Mecocci, P., Simmons, A., Soininen, H., et al. (2009). AddNeuroMed – the European collaboration for the discovery of novel biomarkers for Alzheimer’s disease. Ann N Y Acad Sci 1180, 36–46.
Lowenthal, M.S., Mehta, A.I., Frogale, K., Bandle, R.W., Araujo, R.P., Hood, B.L., et al. (2005). Analysis of albumin-associated peptides and proteins from ovarian cancer patients. Clin Chem 51, 1933–1945.
Matheson, L.A., Duong, T.T., Rosenberg, A.M., and Yeung, R.S.M. (2008). Assessment of sample collection and storage methods for multicenter immunologic research in children. J Immunol Methods 339, 82–89.
Omenn, G.S., States, D.J., Adamski, M., Blackwell, T.W., Menon, R., Hermjakob, H., et al. (2005). Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5, 3226–3245.
O’Mullan, P., Craft, D., Yi, J., and Gelfand, C. (2009). Thrombin induces broad spectrum proteolysis in human serum samples. Clin Chem Lab Med 47, 685–693.
Paasch, U., Grunewald, S., Wuendrich, K., Jope, T., and Glander, H.-J. (2005). Immunomagnetic removal of cryo-damaged human spermatozoa. Asian J Androl 7, 61–69.
Paulovich, A.G., Billheimer, D., Ham, A.-J.L., Vega-Montoto, L., Rudnick, P.A., Tabb, D.L., et al. (2010). Interlaboratory study characterizing a yeast performance standard for benchmarking LC-MS platform performance. Mol Cell Proteomics 9, 242–254.
Penno, M.A., Ernst, M., and Peter, H. (2009). Optimal preparation methods for automated matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling of low molecular weight proteins and peptides. Rapid Commun Mass Spectrom 23, 2656–2662.
Piersma, S.R., Broxterman, H.J., Kapci, M., de Haas, R.R., Hoekman, K., Verheul, H.M.W., et al. (2009). Proteomics of the TRAP-induced platelet releasate. J Proteomics 72, 91–109.
Pikal-Cleland, K., Cleland, J., Anchordoquy, T., and Carpenter, J. (2002). Effect of glycine on pH changes and protein stability during freeze-thawing in phosphate buffer systems. J Pharm Sci 91, 1969–1979.
Plavina, T., Wakshull, E., Hancock, W.S., and Hincapie, M. (2007). Combination of abundant protein depletion and multi-lectin affinity chromatography (M-LAC) for plasma protein biomarker discovery. J Proteome Res 6, 662–671.
Rai, A.J., Gelfand, C.A., Haywood, B.C., Warunek, D.J., Yi, J., Schuchard, M.D., et al. (2005). HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 5, 3262–3277.
Roche, S., Tiers, L., Provansal, M., Seveno, M., Piva, M.-T., Jouin, P., et al. (2009). Depletion of one, six, twelve or twenty major blood proteins before proteomic analysis: the more the better? J Proteomics 72, 945–951.
Rudnick, P.A., Clauser, K.R., Kilpatrick, L.E., Tchekhovskoi, D.V., Neta, P., Blonder, N., et al. (2010). Performance metrics for liquid chromatography-tandem mass spectrometry systems in proteomics analyses. Mol Cell Proteomics 9, 225–241.
Salahudeen, A.K., Huang, H., Joshi, M., Moore, N.A., and Jenkins, J.K. (2003). Involvement of the mitochondrial pathway in cold storage and rewarming-associated apoptosis of human renal proximal tubular cells. Am J Transplant 3, 273–280.
Schuchard, M.D., Mehigh, R.J., Cockrill, S.L., Lipscomb, G.T., Stephan, J.D., Wildsmith, J., et al. (2005). Artifactual isoform profile modification following treatment of human plasma or serum with protease inhibitor, monitored by 2-dimensional electrophoresis and mass spectrometry. BioTechniques 39, 239–247.
Seam, N., Gonzales, D.A., Kern, S.J., Hortin, G.L., Hoehn, G.T., and Suffredini, A.F. (2007). Quality control of serum albumin depletion for proteomic analysis. Clin Chem 53, 1915–1920.
Sherry, S., Alkjaersig, N., and Fletcher, A.P. (1965). Comparative activity of thrombin on substituted arginine and lysine esters. Am J Physiol 209, 577–583.
Suontaka, A.M., Silveira, A., Söderström, T., and Blombäck, M. (2005). Occurrence of cold activation of transfusion plasma during storage at +4 degrees C. Vox Sang 88, 172–180.
Tammen, H., Schulte, I., Hess, R., Menzel, C., Markus, K., Mohring, T., et al. (2005). Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display. Proteomics 5, 3414–3422.
Tang, H.-Y., Ali-Khan, N., Echan, L.A., Levenkova, N., Rux, J.J., and Speicher, D.W. (2005). A novel four-dimensional strategy combining protein and peptide separation methods enables detection of low-abundance proteins in human plasma and serum proteomes. Proteomics 5, 3329–3342.
Troyer, D. (2008). Biorepository standards and protocols for collecting, processing, and storing human tissues. Methods Mol Biol 441, 192–220.
van der Woude, F., Schnuelle, P., and Yard, B. (2004). Preconditioning strategies to limit graft immunogenicity and cold ischemic organ injury. J Investig Med 52, 323–329.
Villanueva, J., Nazarian, A., Lawlor, K., Yi, S.S., Robbins, R.J., and Tempst, P. (2008). A sequence-specific exopeptidase activity test (SSEAT) for “functional” biomarker discovery. Mol Cell Proteomics 7, 509–518.
Villanueva, J., Shaffer, D.R., Philip, J., Chaparro, C.A., Erdjument-Bromage, H., Olshen, A.B., et al. (2006). Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 116, 271–284.
Vitzthum, F., Behrens, F., Anderson, N.L., and Shaw, J.H. (2005). Proteomics: from basic research to diagnostic application. A review of requirements & needs. J Proteome Res 4, 1086–1097.
Washburn, M.P., Ulaszek, R.R., and Yates, J.R. (2003). Reproducibility of quantitative proteomic analyses of complex biological mixtures by multidimensional protein identification technology. Anal Chem 75, 5054–5061.
Whiteaker, J.R., Zhang, H., Zhao, L., Wang, P., Kelly-Spratt, K.S., Ivey, R.G., et al. (2007). Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer. J Proteome Res 6, 3962–3975.
Wood, W. (1991). “Matrix effects” in immunoassays. Scand J Clin Lab Invest Suppl 205, 105–112.
Yi, J., Kim, C., and Gelfand, C.A. (2007). Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma. J Proteome Res 6, 1768–1781.
Yi, J., Liu, Z., Craft, D., O’Mullan, P., Ju, G., and Gelfand, C.A. (2008). Intrinsic peptidase activity causes a sequential multi-step reaction (SMSR) in digestion of human plasma peptides. J Proteome Res 7, 5112–5118.
Yiu, W.-K., Cheng, S.W.K., and Sumpio, B.E. (2006). Vascular smooth muscle cell apoptosis induced by “supercooling” and rewarming. J Vasc Interv Radiol 17, 1971–1977.
Yoshimura, T., Fujita, K., Kawakami, S., Takeda, K., Chan, S., Beligere, G., et al. (2008). Stability of pro-gastrin-releasing peptide in serum versus plasma. Tumor Biol 29, 224–230.
Zheng, X., Baker, H., and Hancock, W.S. (2006). Analysis of the low molecular weight serum peptidome using ultrafiltration and a hybrid ion trap-Fourier transform mass spectrometer. J Chromatogr A 1120, 173–184.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Gelfand, C.A., Omenn, G.S. (2011). Preanalytical Variables for Plasma and Serum Proteome Analyses. In: Ivanov, A., Lazarev, A. (eds) Sample Preparation in Biological Mass Spectrometry. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0828-0_16
Download citation
DOI: https://doi.org/10.1007/978-94-007-0828-0_16
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-0758-0
Online ISBN: 978-94-007-0828-0
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)